drugset / Trial / NCT06580145
Leucine in Midlife Depression
RandomizedParallel-groupTriple-blindTreatment
Summary
The study aims to investigate the effects of a 6-week leucine challenge on brain chemistry, connectivity, and behavior in people with midlife depression. The researchers will compare the leucine and an active comparator arm (lysine) for 6 weeks.
Timeline
- Start
- 2025-02-01
- Primary completion
- 2028-06
- Completion
- 2029-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | L-Lysine | Other / unclassified | 6 g | Oral |
| Subject | amino acids | Unknown | 4.31 g | Oral |